Signal requirements for activation of leukaemic T cells from a chronic lymphocytic leukaemia (T-CLL)

M. R. Zocchi, A. Poggi, S. Heltai, A. Villa, L. Inverardi, A. Vicari, M. G. Sabbadin, M. Ferrarini

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

In order to define the signal requirements for leukaemic T cell activation, the proliferation and interleukin-2 (IL-2) production of peripheral lymphocytes from a patient with a HTLV-I-, CD4+, CD45RA+ CD45RO+ CD25- T-CLL were evaluated after the delivery of different stimuli. Unlike resting CD4+ normal T lymphocytes that can be activated only by a two-signal stimulation, T-CLL cells proliferated and released IL-2 in response to a pair of anti-CD2 monoclonal antibodies (MoAbs) or concavanalin A (Con A) in the absence of both accessory cells (AC) and phorbol myristate acetate (PMA). The two stimuli were also able to induce CD25 expression within 12-20 h on the majority of T-CLL cells. A response to anti-CD3 and anti-CD28 MoAbs was detected only in the presence of PMA, similar to that observed in normal resting T lymphocytes matched for phenotype. Both Con A- and CD2-induced proliferation were strongly inhibited by the addition of anti-CD25 MoAb. Furthermore, T-CLL lymphocytes acquired anti-tumour lytic activity after culture in the presence of PMA and ionomycin. We conclude that HTLV1- CD25- T-CLL can be characterized not only by morphological and phenotypical studies but also on the basis of signal requirements for cell activation.

Original languageEnglish
Pages (from-to)108-113
Number of pages6
JournalClinical and Experimental Immunology
Volume82
Issue number1
Publication statusPublished - 1990

Fingerprint

T-Cell Prolymphocytic Leukemia
Tetradecanoylphorbol Acetate
T-Lymphocytes
Interleukin-2
Monoclonal Antibodies
Lymphocytes
Ionomycin
Human T-lymphotropic virus 1
Cell Proliferation
Phenotype
Neoplasms

Keywords

  • activation
  • leukaemia
  • lymphocytes

ASJC Scopus subject areas

  • Immunology

Cite this

Signal requirements for activation of leukaemic T cells from a chronic lymphocytic leukaemia (T-CLL). / Zocchi, M. R.; Poggi, A.; Heltai, S.; Villa, A.; Inverardi, L.; Vicari, A.; Sabbadin, M. G.; Ferrarini, M.

In: Clinical and Experimental Immunology, Vol. 82, No. 1, 1990, p. 108-113.

Research output: Contribution to journalArticle

Zocchi, M. R. ; Poggi, A. ; Heltai, S. ; Villa, A. ; Inverardi, L. ; Vicari, A. ; Sabbadin, M. G. ; Ferrarini, M. / Signal requirements for activation of leukaemic T cells from a chronic lymphocytic leukaemia (T-CLL). In: Clinical and Experimental Immunology. 1990 ; Vol. 82, No. 1. pp. 108-113.
@article{e3470435bc664130bf8be860c6e979c6,
title = "Signal requirements for activation of leukaemic T cells from a chronic lymphocytic leukaemia (T-CLL)",
abstract = "In order to define the signal requirements for leukaemic T cell activation, the proliferation and interleukin-2 (IL-2) production of peripheral lymphocytes from a patient with a HTLV-I-, CD4+, CD45RA+ CD45RO+ CD25- T-CLL were evaluated after the delivery of different stimuli. Unlike resting CD4+ normal T lymphocytes that can be activated only by a two-signal stimulation, T-CLL cells proliferated and released IL-2 in response to a pair of anti-CD2 monoclonal antibodies (MoAbs) or concavanalin A (Con A) in the absence of both accessory cells (AC) and phorbol myristate acetate (PMA). The two stimuli were also able to induce CD25 expression within 12-20 h on the majority of T-CLL cells. A response to anti-CD3 and anti-CD28 MoAbs was detected only in the presence of PMA, similar to that observed in normal resting T lymphocytes matched for phenotype. Both Con A- and CD2-induced proliferation were strongly inhibited by the addition of anti-CD25 MoAb. Furthermore, T-CLL lymphocytes acquired anti-tumour lytic activity after culture in the presence of PMA and ionomycin. We conclude that HTLV1- CD25- T-CLL can be characterized not only by morphological and phenotypical studies but also on the basis of signal requirements for cell activation.",
keywords = "activation, leukaemia, lymphocytes",
author = "Zocchi, {M. R.} and A. Poggi and S. Heltai and A. Villa and L. Inverardi and A. Vicari and Sabbadin, {M. G.} and M. Ferrarini",
year = "1990",
language = "English",
volume = "82",
pages = "108--113",
journal = "Clinical and Experimental Immunology",
issn = "0009-9104",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Signal requirements for activation of leukaemic T cells from a chronic lymphocytic leukaemia (T-CLL)

AU - Zocchi, M. R.

AU - Poggi, A.

AU - Heltai, S.

AU - Villa, A.

AU - Inverardi, L.

AU - Vicari, A.

AU - Sabbadin, M. G.

AU - Ferrarini, M.

PY - 1990

Y1 - 1990

N2 - In order to define the signal requirements for leukaemic T cell activation, the proliferation and interleukin-2 (IL-2) production of peripheral lymphocytes from a patient with a HTLV-I-, CD4+, CD45RA+ CD45RO+ CD25- T-CLL were evaluated after the delivery of different stimuli. Unlike resting CD4+ normal T lymphocytes that can be activated only by a two-signal stimulation, T-CLL cells proliferated and released IL-2 in response to a pair of anti-CD2 monoclonal antibodies (MoAbs) or concavanalin A (Con A) in the absence of both accessory cells (AC) and phorbol myristate acetate (PMA). The two stimuli were also able to induce CD25 expression within 12-20 h on the majority of T-CLL cells. A response to anti-CD3 and anti-CD28 MoAbs was detected only in the presence of PMA, similar to that observed in normal resting T lymphocytes matched for phenotype. Both Con A- and CD2-induced proliferation were strongly inhibited by the addition of anti-CD25 MoAb. Furthermore, T-CLL lymphocytes acquired anti-tumour lytic activity after culture in the presence of PMA and ionomycin. We conclude that HTLV1- CD25- T-CLL can be characterized not only by morphological and phenotypical studies but also on the basis of signal requirements for cell activation.

AB - In order to define the signal requirements for leukaemic T cell activation, the proliferation and interleukin-2 (IL-2) production of peripheral lymphocytes from a patient with a HTLV-I-, CD4+, CD45RA+ CD45RO+ CD25- T-CLL were evaluated after the delivery of different stimuli. Unlike resting CD4+ normal T lymphocytes that can be activated only by a two-signal stimulation, T-CLL cells proliferated and released IL-2 in response to a pair of anti-CD2 monoclonal antibodies (MoAbs) or concavanalin A (Con A) in the absence of both accessory cells (AC) and phorbol myristate acetate (PMA). The two stimuli were also able to induce CD25 expression within 12-20 h on the majority of T-CLL cells. A response to anti-CD3 and anti-CD28 MoAbs was detected only in the presence of PMA, similar to that observed in normal resting T lymphocytes matched for phenotype. Both Con A- and CD2-induced proliferation were strongly inhibited by the addition of anti-CD25 MoAb. Furthermore, T-CLL lymphocytes acquired anti-tumour lytic activity after culture in the presence of PMA and ionomycin. We conclude that HTLV1- CD25- T-CLL can be characterized not only by morphological and phenotypical studies but also on the basis of signal requirements for cell activation.

KW - activation

KW - leukaemia

KW - lymphocytes

UR - http://www.scopus.com/inward/record.url?scp=0025013496&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025013496&partnerID=8YFLogxK

M3 - Article

C2 - 1976463

AN - SCOPUS:0025013496

VL - 82

SP - 108

EP - 113

JO - Clinical and Experimental Immunology

JF - Clinical and Experimental Immunology

SN - 0009-9104

IS - 1

ER -